Group One Trading’s ANI Pharmaceuticals ANIP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-700
| Closed | -$64.1K | – | 8053 |
|
|
2025
Q3 | $64.1K | Hold |
700
| – | – | ﹤0.01% | 5753 |
|
|
2025
Q2 | $45.7K | Buy |
+700
| New | +$45.6K | ﹤0.01% | 5649 |
|
|
2024
Q4 | – | Sell |
-300
| Closed | -$17.9K | – | 7215 |
|
|
2024
Q3 | $17.9K | Buy |
+300
| New | +$18.3K | ﹤0.01% | 5287 |
|
|
2023
Q3 | – | Sell |
-400
| Closed | -$21.5K | – | 7603 |
|
|
2023
Q2 | $21.5K | Hold |
400
| – | – | ﹤0.01% | 5947 |
|
|
2023
Q1 | $15.9K | Buy |
+400
| New | +$16.9K | ﹤0.01% | 5661 |
|
|
2022
Q4 | – | Sell |
-100
| Closed | -$32K | – | 7175 |
|
|
2022
Q3 | $32K | Buy |
+100
| New | +$3.42K | ﹤0.01% | 5743 |
|
|
2022
Q2 | – | Sell |
-400
| Closed | -$11K | – | 7742 |
|
|
2022
Q1 | $11K | Buy |
+400
| New | +$14.9K | ﹤0.01% | 7105 |
|
|
2020
Q2 | – | Sell |
-200
| Closed | -$8K | – | 5754 |
|
|
2020
Q1 | $8K | Hold |
200
| – | – | ﹤0.01% | 4624 |
|
|
2019
Q4 | $12K | Sell |
200
-100
| -33% | -$6.62K | ﹤0.01% | 4539 |
|
|
2019
Q3 | $22K | Sell |
300
-5,000
| -94% | -$374K | ﹤0.01% | 4321 |
|
|
2019
Q2 | $436K | Buy |
+5,300
| New | +$377K | ﹤0.01% | 2243 |
|
|
2018
Q3 | – | Sell |
-38,000
| Closed | -$2.54M | – | 5150 |
|
|
2018
Q2 | $2.54M | Sell |
38,000
-5,000
| -12% | -$312K | 0.02% | 963 |
|
|
2018
Q1 | $2.5M | Buy |
43,000
+36,400
| +552% | +$2.31M | 0.03% | 852 |
|
|
2017
Q4 | $425K | Buy |
6,600
+100
| +2% | +$6.22K | ﹤0.01% | 2382 |
|
|
2017
Q3 | $341K | Buy |
6,500
+5,500
| +550% | +$262K | ﹤0.01% | 2364 |
|
|
2017
Q2 | $47K | Buy |
1,000
+100
| +11% | +$4.82K | ﹤0.01% | 3534 |
|
|
2017
Q1 | $45K | Sell |
900
-5,900
| -87% | -$331K | ﹤0.01% | 3473 |
|
|
2016
Q4 | $412K | Sell |
6,800
-4,500
| -40% | -$275K | ﹤0.01% | 1907 |
|
|
2016
Q3 | $750K | Buy |
11,300
+5,700
| +102% | +$357K | 0.01% | 1488 |
|
|
2016
Q2 | $313K | Sell |
5,600
-6,400
| -53% | -$311K | ﹤0.01% | 2085 |
|
|
2016
Q1 | $404K | Sell |
12,000
-37,500
| -76% | -$1.27M | 0.01% | 1834 |
|
|
2015
Q4 | $2.23M | Buy |
49,500
+25,400
| +105% | +$1.09M | 0.03% | 788 |
|
|
2015
Q3 | $952K | Buy |
24,100
+3,400
| +16% | +$193K | 0.01% | 1285 |
|
|
2015
Q2 | $1.28M | Buy |
20,700
+12,700
| +159% | +$756K | 0.02% | 1038 |
|
|
2015
Q1 | $500K | Buy |
8,000
+1,000
| +14% | +$60.8K | 0.01% | 1598 |
|
|
2014
Q4 | $395K | Buy |
+7,000
| New | +$309K | 0.01% | 1737 |
|
|
2014
Q1 | – | Sell |
-115,300
| Closed | -$2.31M | – | 5151 |
|
|
2013
Q4 | $2.31M | Sell |
115,300
-500
| -0.4% | -$6.48K | 0.03% | 571 |
|
|
2013
Q3 | $1.13M | Buy |
115,800
+96,517
| +501% | +$696K | 0.02% | 925 |
|
|
2013
Q2 | $116K | Buy |
+19,283
| New | +$135K | ﹤0.01% | 2677 |
|
Other funds holding ANIP
VCM
SCM
TCM
GAM
DTC
Group One Trading's ANIP Position: Q1 2026 in Review
Group One Trading reduced its ANI Pharmaceuticals (ANIP) stake by 50% in Q1 2026, selling an estimated $7.8K and leaving 100 shares worth $7.69K. The position accounts for ﹤0.01% of the portfolio, ranked #6509.
Group One Trading first reported a position in ANIP in Q2 2013 and has held it in 13 quarters since. The position peaked at $292K in Q3 2019. 280 funds tracked by Wall St. Rank hold ANIP as of Q1 2026.
- Group One Trading held 100 shares of ANI Pharmaceuticals worth $7.69K as of Q1 2026.
- Group One Trading sold 100 ANI Pharmaceuticals shares in Q1 2026, an estimated $7.8K.
- ANI Pharmaceuticals made up ﹤0.01% of Group One Trading's portfolio in Q1 2026, its #6509 holding.
- Group One Trading first reported a position in ANI Pharmaceuticals in Q2 2013 and has held it in 13 quarters since.
- Group One Trading's ANI Pharmaceuticals position peaked at $292K in Q3 2019.
- 280 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q1 2026.
Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.